
CAS 1435893-78-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
NoxA1ds
CAS :Selective NOX1 inhibitor; IC50 at 20 nM; spares NOX2/4/5 and xanthine oxidase; reduces HT-29 O2- and hinders VEGF-induced cell migration.Formule :C50H88N14O15Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1125.33NoxA1ds
CAS :Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormule :C50H88N14O15Masse moléculaire :1,125.33 g/molNoxA1ds
CAS :<p>NoxA1ds is a reactive drug molecule that inhibits the enzyme nitric oxide synthase. This class of drugs has been shown to inhibit endothelial cell proliferation, but its clinical relevance is not yet clear. It has been shown to be active in the treatment of inflammatory bowel disease, as well as cancer and chronic kidney disease. NoxA1ds binds to the enzyme nitric oxide synthase and prevents it from synthesizing nitric oxide, thereby inhibiting angiogenesis. The mechanism of action for this drug is similar to that of antiangiogenic therapy.</p>Formule :C50H88N14O15Degré de pureté :Min. 95%Masse moléculaire :1,125.3 g/mol



